BUZZ-Vectura: all-time high on completing asthma therapy trial – Reuters


Proactive Investors USA & Canada

BUZZ-Vectura: all-time high on completing asthma therapy trial
Reuters
… ** Vectura up over 5 pct to all-time high & top FTSE 250 mid-cap gainer after it completes a clinical trial for generic asthma therapy VR315 in the U.S., bringing it closer to a commercial launch. ** Drug developer also reveals that its partner for
Drug developer Vectura on a high as asthma treatment completes US clinical trialSwindon Business News
Vectura Group Completes Clinical Trial For VR315 Asthma TreatmentLondon South East (registration) (blog)
Vectura Completes Clinical Trial For VR315 In US; Stock UpNasdaq
Proactive Investors USA & Canada –Yahoo Finance UK –Stock Market Wire
all 7 news articles »

View full post on asthma – Google News

US asthma rates at all-time high, CDC says – Los Angeles Times


FOX News Radio

US asthma rates at all-time high, CDC says
Los Angeles Times
By Thomas H. Maugh II The proportion of Americans with asthma increased from 7.3% in 2001 to 8.4% in 2010, marking the highest level ever, the US Centers for Disease Control and Prevention said Tuesday. In 2010, an estimated 18.7 million adults and 7
Asthma Cases Reach New HighMedPage Today
Survey reveals growing national impact of asthmaMarketWatch (press release)
CDC: ASTHMA A COSTLY, GROWING AILMENTFOX News Radio

all 19 news articles »

View full post on asthma – Google News